Stock Price
3.24
Daily Change
0.04 1.25%
Monthly
4.52%
Yearly
32.24%
Q3 Forecast
3.18

Acasti Pharma reported $0 in Cost of Sales for its fiscal quarter ending in March of 2022.


Cost Of Sales Change Date
Addus HomeCare USD 239.48M 9.45M Jun/2025
Amarin USD 16.89M 18.51M Mar/2025
Cassava Sciences USD 5.12M 5.02M Jun/2025
Knight Therapeutics CAD 47.25M 990K Sep/2024
Option Care Health USD 1.15B 77.12M Jun/2025
Organigram Holdings CAD 44.65M 2.96M Jun/2025
Tilray USD 149.73M 9.39M Nov/2024